ATG5 and cancer: To address the challenge of cell survival in PDT-resistant cancer cells, a self-powered TENG has been developed to deliver siRNA targeting genes such as Bcl-2, ATG5 and others to overcome cell survival and proliferation in PDT-resistant cancer cells 33.